GENEVA, Sept. 21 -- BEIJING BAYLX PHARMACEUTICAL CO., LTD (1st To 3rd Floors, Building 5, No.16 Baoshennan Street, Daxing Biomedical Industry Base, Zhongguancun Science And Technology Park,Daxing District, Beijing 102600), 北京贝来药业有限公司 (中国北京市大兴区中关村科技园区大兴生物医药产业基地宝参南街16号院5号楼第1层至第3层) filed a patent application (PCT/CN2025/093638) for "PHARMACEUTICAL USE OF STEM CELL MODIFIED BASED ON SINGLE-DOMAIN ANTIBODY GENES FOR...
Click here to read full article from source
इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया
हमे संपर्क करें.
